No link found between early pregnancy cannabis use and birth complications

This study examined whether maternal cannabis use during early pregnancy affects birth outcomes using data from the National Birth Defects Prevention Study. Researchers surveyed pregnant women about their cannabis use in the first six months of pregnancy and tracked two key outcomes: preterm birth (delivery before 37 weeks) and small for gestational age (SGA) births. Only 3% of the study sample reported cannabis use during early pregnancy, with more than half of those users stopping after the second month. The findings suggest that early pregnancy cannabis exposure was not significantly associated with either preterm birth or SGA outcomes.

The statistical analysis revealed no significant link between cannabis use and preterm birth (adjusted odds ratio = 1.27) or SGA (adjusted odds ratio = 1.00), indicating these risks were comparable between cannabis users and non-users. This finding is particularly notable given growing concerns about substance use during pregnancy and the increasing prevalence of cannabis among reproductive-age women. However, researchers emphasized the need for additional studies to fully understand the long-term effects and potential risks across different populations and usage patterns.

These results provide some reassurance for expecting mothers, but they represent just one piece of a larger puzzle. The study's relatively small number of cannabis users and reliance on self-reporting mean conclusions should be viewed with appropriate caution. Healthcare providers and pregnant women should continue discussing cannabis use during pregnancy, as additional research is needed to clarify any potential subtle or delayed effects.